This is a first-in-human clinical study to evaluate the safety, tolerability and efficacy of RXRG001 administered in the ducts of the parotid glands in adult p…

Radiation-Induced Xerostomia and Hyposalivation

~Estimated

~$10 – $8,750

RiboX Therapeutics Ltd.NCT06714253

Phase 1

UW23129: A Phase I Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia

The goal of this clinical trial is to evaluate the safety and tolerability of injecting certain cells produced in bone marrow called mesenchymal stromal cells …

XerostomiaGraft-versus-host-diseaseSjogren's Disease

~Estimated

~$10 – $6,250

University of Wisconsin, MadisonNCT06392711

Phase 1

A Phase I Study of d-Limonene With Concurrent Radiation and Platinum Based Chemotherapy for Xerostomia Prevention in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

This study explores the safety of d-limonene, a commercially-available dietary supplement (food) as a potential therapeutic for the severe dry mouth (xerostomi…

Xerostomia

~Estimated

~$10 – $6,250

Stanford UniversityNCT04392622